These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9584050)

  • 1. Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.
    Willén R; Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J
    Anticancer Res; 1998; 18(1B):667-76. PubMed ID: 9584050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
    Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Grazzini G; Pacini P; Muraca MG
    Gynecol Oncol; 1996 Mar; 60(3):409-11. PubMed ID: 8774648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
    Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
    Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal tamoxifen treatment and endometrial pathology.
    Cohen I; Altaras MM; Shapira J; Tepper R; Beyth Y
    Obstet Gynecol Surv; 1994 Dec; 49(12):823-9. PubMed ID: 7885659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma.
    Lindahl B; Andolf E; Ingvar C; Ranstam J; Willén R
    Anticancer Res; 2008; 28(2B):1259-62. PubMed ID: 18505063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients.
    Cohen I; Rosen DJ; Shapira J; Cordoba M; Gilboa S; Altaras MM; Yigael D; Beyth Y
    Gynecol Oncol; 1994 Feb; 52(2):185-90. PubMed ID: 8314137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrasound endometrium follow-up during tamoxifen treatment: Really not reliable or useful after all?].
    Burkart C; Wight E; Pók J; Kernen B; Traber M; Haller U; Bajka M
    Ultraschall Med; 2001 Jun; 22(3):136-42. PubMed ID: 11484445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen.
    Tepper R; Cohen I; Altaras M; Shapira J; Cordoba M; Dror Y; Beyth Y
    J Ultrasound Med; 1994 Aug; 13(8):635-40. PubMed ID: 7933033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ultrasound in the detection of endometrial pathologies in asymptomatic postmenopausal breast cancer patients with tamoxifen treatment.
    Cohen I; Beyth Y; Tepper R
    Obstet Gynecol Surv; 1998 Jul; 53(7):429-38. PubMed ID: 9662729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen.
    Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J; Willén R
    Anticancer Res; 1997; 17(5B):3821-4. PubMed ID: 9427787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies.
    Cohen I; Tepper R; Rosen DJ; Shapira J; Cordoba M; Dror Y; Altaras M; Beyth Y
    Gynecol Oncol; 1994 Oct; 55(1):138-43. PubMed ID: 7959255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal manipulation and gynaecological cancer: the tamoxifen dilemma.
    Ross D; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):63-8. PubMed ID: 7742519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of endometrial abnormalities in breast cancer patients taking tamoxifen: the need for gynaecologic surveillance.
    Sinawat S; Chiyabutra T
    Asian Pac J Cancer Prev; 2004; 5(2):183-7. PubMed ID: 15244522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
    Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
    J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.